Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	HIF-1 signaling pathway	5/109	9.74361863668157e-08	6.8692511388605076e-06	76.57692307692308	-215.37975158818497	AKT1;FLT1;MTOR;PIK3CA;TEK
KEGG_2021_Human	Rap1 signaling pathway	6/210	5.536037150501879e-08	6.8692511388605076e-06	57.8235294117647	-190.69206916659132	AKT1;FLT1;GNAQ;KDR;PIK3CA;TEK
KEGG_2021_Human	Growth hormone synthesis, secretion and action	5/119	1.5152951972796427e-07	7.12188742721432e-06	69.7719298245614	-200.1131285284535	AKT1;GNA11;GNAQ;MTOR;PIK3CA
KEGG_2021_Human	GnRH secretion	4/64	7.261673977114379e-07	2.5597400769328188e-05	88.97777777777777	-197.79231847075658	AKT1;GNA11;GNAQ;PIK3CA
KEGG_2021_Human	PI3K-Akt signaling pathway	6/354	1.2285229960677564e-06	3.4644348489110726e-05	33.275862068965516	-116.99904255484728	AKT1;FLT1;KDR;MTOR;PIK3CA;TEK
KEGG_2021_Human	Human immunodeficiency virus 1 infection	5/212	2.6891423738912685e-06	6.31948457864448e-05	37.97584541062802	-120.26946900483341	AKT1;GNA11;GNAQ;MTOR;PIK3CA
KEGG_2021_Human	Human cytomegalovirus infection	5/225	3.60640803391693e-06	7.264336182604101e-05	35.67272727272727	-113.77866048874807	AKT1;GNA11;GNAQ;MTOR;PIK3CA
KEGG_2021_Human	Ras signaling pathway	5/232	4.193632481505705e-06	7.391277248653805e-05	34.541850220264315	-110.54645043588327	AKT1;FLT1;KDR;PIK3CA;TEK
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	7.437951803345821e-05	54.21768707482993	-134.5540755438832	AKT1;GNA11;GNAQ;PIK3CA
KEGG_2021_Human	Cholinergic synapse	4/113	7.1460852432057485e-06	0.00010075980192920105	48.678899082568805	-123.22339060338247	AKT1;GNA11;GNAQ;PIK3CA
KEGG_2021_Human	Spinocerebellar ataxia	4/143	1.820556871612203e-05	0.0002333622899066551	38.02877697841727	-100.11084528203472	AKT1;GNAQ;MTOR;PIK3CA
KEGG_2021_Human	VEGF signaling pathway	3/59	4.2829644076396207e-05	0.0005032483178976554	61.316326530612244	-109.395777314067	AKT1;KDR;PIK3CA
KEGG_2021_Human	Acute myeloid leukemia	3/67	6.278481738010982e-05	0.0006612058356978685	53.598214285714285	-98.46843432757142	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Proteoglycans in cancer	4/205	7.503044944089289e-05	0.0006612058356978685	26.092868988391377	-71.58256188469439	AKT1;KDR;MTOR;PIK3CA
KEGG_2021_Human	Focal adhesion	4/201	6.947038219704022e-05	0.0006612058356978685	26.63620981387479	-72.95515241997339	AKT1;FLT1;KDR;PIK3CA
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.0006612058356978685	51.17910447761194	-94.92366080084827	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Glioma	3/75	8.803803111601103e-05	0.0007175035979622383	47.595238095238095	-89.5568748406007	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.0007175035979622383	46.93737769080235	-88.55605413655218	AKT1;MTOR;PIK3CA
KEGG_2021_Human	ErbB signaling pathway	3/85	0.00012793645194335274	0.0009305621010087561	41.73867595818815	-80.46318508481777	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.0009305621010087561	41.230636833046475	-79.65388581050792	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Calcium signaling pathway	4/240	0.0001385943554693892	0.0009305621010087561	22.124293785310734	-61.303577347609085	FLT1;GNA11;GNAQ;KDR
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0009350198868391731	21.55922865013774	-59.801482853342776	AKT1;GLMN;MTOR;PIK3CA
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/89	0.0001467151296543735	0.0009350198868391731	39.777408637873755	-77.31969343552903	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Prostate cancer	3/97	0.00018948670381727933	0.0011017330949841524	36.35562310030395	-71.7056117119453	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Choline metabolism in cancer	3/98	0.0001953427473376157	0.0011017330949841524	35.96842105263158	-71.05939608138371	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Longevity regulating pathway	3/102	0.00021994493140062025	0.0011486013084254613	34.497835497835496	-68.58379435140506	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0011486013084254613	34.497835497835496	-68.58379435140506	GNA11;GNAQ;PIK3CA
KEGG_2021_Human	Pathways in cancer	5/531	0.00023006625856898829	0.001158547944936691	14.338403041825096	-46.44758767649085	AKT1;GNA11;GNAQ;MTOR;PIK3CA
KEGG_2021_Human	Insulin resistance	3/108	0.00026049631963660937	0.0012665510713366181	32.50204081632653	-65.16806085544759	AKT1;MTOR;PIK3CA
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.0014261450276961307	17.880459770114943	-49.762697732575255	AKT1;FLT1;KDR;TEK
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.0015567273472804437	28.87409200968523	-58.78131250266827	AKT1;MTOR;PIK3CA
KEGG_2021_Human	AMPK signaling pathway	3/120	0.0003555398588827732	0.0015567273472804437	29.124542124542124	-59.230009444204136	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0015567273472804437	29.379310344827587	-59.68521503911596	AKT1;GNAQ;PIK3CA
KEGG_2021_Human	Platelet activation	3/124	0.0003915863175160221	0.0016239314932282093	28.14757969303424	-57.47285652579811	AKT1;GNAQ;PIK3CA
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.0018975403691614738	25.375266524520256	-52.38188378130509	AKT1;GNAQ;PIK3CA
KEGG_2021_Human	Apelin signaling pathway	3/137	0.0005248515914701949	0.0018975403691614738	25.375266524520256	-52.38188378130509	AKT1;GNAQ;MTOR
KEGG_2021_Human	Insulin signaling pathway	3/137	0.0005248515914701949	0.0018975403691614738	25.375266524520256	-52.38188378130509	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Estrogen signaling pathway	3/137	0.0005248515914701949	0.0018975403691614738	25.375266524520256	-52.38188378130509	AKT1;GNAQ;PIK3CA
KEGG_2021_Human	Autophagy	3/137	0.0005248515914701949	0.0018975403691614738	25.375266524520256	-52.38188378130509	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.001930401984056979	24.99579831932773	-51.672386684351224	AKT1;KDR;PIK3CA
KEGG_2021_Human	Breast cancer	3/147	0.0006451123837261741	0.00220061342954624	23.583333333333332	-49.00315377085699	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.00220061342954624	23.25440313111546	-48.37496566440217	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Phospholipase D signaling pathway	3/148	0.0006580280370873506	0.00220061342954624	23.417733990147784	-48.687210890592894	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Alzheimer disease	4/369	0.0007223109472324288	0.002314678262722101	14.069406392694065	-38.837531411044004	AKT1;GNAQ;MTOR;PIK3CA
KEGG_2021_Human	mTOR signaling pathway	3/154	0.0007390260491982426	0.0023156149541544934	22.47019867549669	-46.86692877135684	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Cellular senescence	3/156	0.0007673816433603202	0.002352191558995764	22.170868347338935	-46.2873867313738	AKT1;MTOR;PIK3CA
KEGG_2021_Human	JAK-STAT signaling pathway	3/162	0.000856615716023289	0.0025698471480698672	21.318059299191376	-44.62403509135876	AKT1;MTOR;PIK3CA
KEGG_2021_Human	cGMP-PKG signaling pathway	3/167	0.0009358557046094012	0.0027401368977551213	20.65505226480836	-43.31808643668981	AKT1;GNA11;GNAQ
KEGG_2021_Human	Hepatocellular carcinoma	3/168	0.0009522461559574535	0.0027401368977551213	20.527272727272727	-43.06507884394289	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.003778654498131333	18.161290322580644	-38.30003183551744	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.003779430339971892	17.769924812030077	-37.496518500419114	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.003779430339971892	45.59090909090909	-53.767249912981214	MTOR;PIK3CA
KEGG_2021_Human	Carbohydrate digestion and absorption	2/47	0.001447441406797746	0.003779430339971892	44.57222222222222	-52.81565568615274	AKT1;PIK3CA
KEGG_2021_Human	Chemokine signaling pathway	3/192	0.001402358175894933	0.003779430339971892	17.866213151927436	-37.69462705671507	AKT1;GNAQ;PIK3CA
KEGG_2021_Human	Diabetic cardiomyopathy	3/203	0.0016469262374030193	0.0042221199904331945	16.86	-35.61063787888018	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Regulation of lipolysis in adipocytes	2/55	0.0019779052882580696	0.004980082957935497	37.806603773584904	-46.277866103498205	AKT1;PIK3CA
KEGG_2021_Human	Endometrial cancer	2/58	0.002197307066915163	0.00543544379710593	35.767857142857146	-44.22678458760781	AKT1;PIK3CA
KEGG_2021_Human	Long-term depression	2/60	0.0023497251222600107	0.005712262797218302	34.525862068965516	-42.95708800176444	GNA11;GNAQ
KEGG_2021_Human	Chemical carcinogenesis	3/239	0.0026306580335614905	0.006286826825968986	14.2227602905569	-29.996427445990946	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Cortisol synthesis and secretion	2/65	0.002752148243719554	0.006467548372740952	31.765873015873016	-40.07734547796954	GNA11;GNAQ
KEGG_2021_Human	Renal cell carcinoma	2/69	0.0030959091544989293	0.006928939536259508	29.854477611940297	-38.032897794694755	AKT1;PIK3CA
KEGG_2021_Human	Fc epsilon RI signaling pathway	2/68	0.0030081604419031007	0.006928939536259508	30.310606060606062	-38.524679686703344	AKT1;PIK3CA
KEGG_2021_Human	Adipocytokine signaling pathway	2/69	0.0030959091544989293	0.006928939536259508	29.854477611940297	-38.032897794694755	AKT1;MTOR
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.007016643256042528	29.41176470588235	-37.553176952571945	AKT1;PIK3CA
KEGG_2021_Human	Non-small cell lung cancer	2/72	0.003366354198306209	0.007191756696381446	28.564285714285713	-36.6281144505518	AKT1;PIK3CA
KEGG_2021_Human	Melanoma	2/72	0.003366354198306209	0.007191756696381446	28.564285714285713	-36.6281144505518	AKT1;PIK3CA
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.007878431727066412	27.006756756756758	-34.90410589940028	AKT1;PIK3CA
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.008795698247541306	25.281645569620252	-32.95657984925952	AKT1;PIK3CA
KEGG_2021_Human	Insulin secretion	2/86	0.00476943508022695	0.009746236903072462	23.761904761904763	-31.205674037146366	GNA11;GNAQ
KEGG_2021_Human	Gap junction	2/88	0.0049885835861889025	0.010048432652180504	23.203488372093023	-30.553595052356073	GNA11;GNAQ
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.010732644105626209	22.16111111111111	-29.32328202848766	AKT1;PIK3CA
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.010732644105626209	21.914835164835164	-29.03004575134454	FLT1;TEK
KEGG_2021_Human	GnRH signaling pathway	2/93	0.005556617161068888	0.010732644105626209	21.914835164835164	-29.03004575134454	GNA11;GNAQ
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	2/97	0.006031622120792857	0.011415826180148915	20.981578947368423	-27.909669646620806	AKT1;PIK3CA
KEGG_2021_Human	Aldosterone synthesis and secretion	2/98	0.0061532112744065075	0.011415826180148915	20.760416666666668	-27.64199341159925	GNA11;GNAQ
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	2/98	0.0061532112744065075	0.011415826180148915	20.760416666666668	-27.64199341159925	GNAQ;PIK3CA
KEGG_2021_Human	Progesterone-mediated oocyte maturation	2/100	0.006399778215208473	0.011568829850569161	20.331632653061224	-27.120602948412195	AKT1;PIK3CA
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.011568829850569161	20.331632653061224	-27.120602948412195	AKT1;PIK3CA
KEGG_2021_Human	Human papillomavirus infection	3/331	0.006599251035795172	0.011778410076545813	10.113240418118467	-20.757683091358754	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.011875638041115189	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.011875638041115189	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.011875638041115189	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	2/106	0.0071664154144845515	0.012174271969184601	19.14423076923077	-25.65956234303792	GNA11;GNAQ
KEGG_2021_Human	Glucagon signaling pathway	2/107	0.00729809140286639	0.012250367711954297	18.95952380952381	-25.42995427691617	AKT1;GNAQ
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.01322589331829809	18.086363636363636	-24.33571316400054	AKT1;PIK3CA
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.014696814535864314	16.98931623931624	-22.939511285821055	AKT1;PIK3CA
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.016468353205087265	15.886	-21.510038502238015	AKT1;PIK3CA
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.016777906287265967	15.631889763779528	-21.1770620526928	AKT1;PIK3CA
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.017087203334759684	15.385658914728682	-20.853034219946885	AKT1;PIK3CA
KEGG_2021_Human	Dopaminergic synapse	2/132	0.010944231033525537	0.01714596195252334	15.265384615384615	-20.69426126847997	AKT1;GNAQ
KEGG_2021_Human	Vascular smooth muscle contraction	2/133	0.011103972768351109	0.01720505670700556	15.146946564885496	-20.537590301958808	GNA11;GNAQ
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.0185205846326934	14.472627737226277	-19.639406588988233	AKT1;PIK3CA
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.019085848367583234	14.157142857142857	-19.21549786230027	AKT1;PIK3CA
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	2/143	0.01275865818396982	0.01913798727595473	14.054964539007091	-19.077689748676264	AKT1;PIK3CA
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	2/150	0.0139780795801668	0.020746412850563355	13.378378378378379	-18.15870698745584	AKT1;GNAQ
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.021628856428724034	12.933006535947712	-17.54750234216727	AKT1;PIK3CA
KEGG_2021_Human	Cushing syndrome	2/155	0.014879426053803059	0.021628856428724034	12.933006535947712	-17.54750234216727	GNA11;GNAQ
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.0219369653120074	12.762903225806452	-17.312716751580805	AKT1;PIK3CA
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.023048772043204966	12.35625	-16.748364182562245	AKT1;PIK3CA
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.025561950282629708	11.614705882352942	-15.707848772731996	AKT1;PIK3CA
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.02816489036138032	6.556709956709956	-12.239051897711217	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.03391547035021027	9.835	-13.147442958027579	AKT1;PIK3CA
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.03769527872226299	9.175233644859814	-12.174459052502558	AKT1;PIK3CA
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.03769527872226299	9.219483568075118	-12.240131856521	AKT1;PIK3CA
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.038306934952270964	9.044930875576037	-11.980722307867735	AKT1;PIK3CA
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.04811615043412289	7.915991902834008	-10.280113155611538	AKT1;PIK3CA
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.058613280853989515	24.790123456790123	-13.876145105511855	PIK3CA
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.058613280853989515	24.790123456790123	-13.876145105511855	GNAQ
KEGG_2021_Human	Huntington disease	2/306	0.05264626136655815	0.0681020445200431	6.384868421052632	-7.910702811009382	GNAQ;MTOR
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.0690785687202895	6.298701298701299	-7.775300015246377	MTOR;PIK3CA
KEGG_2021_Human	Endocrine and other factor-regulated calcium reabsorption	1/53	0.06374115884515756	0.08096849907357852	17.128205128205128	-10.081098986019231	GNAQ
KEGG_2021_Human	Long-term potentiation	1/67	0.07995603885498047	0.1006589417727879	13.47138047138047	-8.082458738692866	GNAQ
KEGG_2021_Human	Renin secretion	1/69	0.08225170002715665	0.1026326522462751	13.071895424836601	-7.854937277937848	GNAQ
KEGG_2021_Human	Inositol phosphate metabolism	1/73	0.0868275630671275	0.10739198589881559	12.339506172839506	-7.43259286356604	PIK3CA
KEGG_2021_Human	Thyroid hormone synthesis	1/75	0.0891077855134448	0.10925389354257145	12.003003003003004	-7.236197160831004	GNAQ
KEGG_2021_Human	Gastric acid secretion	1/76	0.09024597396088518	0.10969553731452424	11.841481481481482	-7.141387005986298	GNAQ
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.11012808888509776	11.68421052631579	-7.04872976578505	PIK3CA
KEGG_2021_Human	Salivary secretion	1/93	0.1094003568916107	0.13072415526878906	9.632850241545894	-5.8073541800756905	GNAQ
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.13267305455000306	4.014270613107822	-4.131104230952899	GNAQ;MTOR
KEGG_2021_Human	Circadian entrainment	1/97	0.11385418156418702	0.13267305455000306	9.226851851851851	-5.553951626329874	GNAQ
KEGG_2021_Human	Phosphatidylinositol signaling system	1/97	0.11385418156418702	0.13267305455000306	9.226851851851851	-5.553951626329874	PIK3CA
KEGG_2021_Human	Melanogenesis	1/101	0.11828795027183354	0.1367098441666273	8.853333333333333	-5.318405524022337	GNAQ
KEGG_2021_Human	Pancreatic secretion	1/102	0.11939326812281527	0.13686545370176384	8.764576457645765	-5.262086311101535	GNAQ
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.14202472207125263	8.345911949685535	-4.994589105830365	MTOR
KEGG_2021_Human	Glutamatergic synapse	1/114	0.13256015588280526	0.14602329671465267	7.822025565388397	-4.655477238055189	GNAQ
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.14602329671465267	7.964964964964965	-4.748494648054986	AKT1
KEGG_2021_Human	Serotonergic synapse	1/113	0.1314697223892576	0.14602329671465267	7.892857142857143	-4.701617375992292	GNAQ
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.14602329671465267	7.822025565388397	-4.655477238055189	PIK3CA
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.16494813174467865	6.7846153846153845	-3.968927686510734	PIK3CA
KEGG_2021_Human	Retrograde endocannabinoid signaling	1/148	0.16890973234869874	0.18320209431666556	5.987150415721844	-3.427000500776257	GNAQ
KEGG_2021_Human	Oxytocin signaling pathway	1/154	0.17518011116339122	0.18855263873311573	5.74800290486565	-3.2620286219941206	GNAQ
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.21453321522928478	4.896958410924891	-2.6658400097237527	AKT1
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.21453321522928478	4.841620626151013	-2.6265948500338347	PIK3CA
KEGG_2021_Human	NOD-like receptor signaling pathway	1/181	0.20287322552436027	0.21453321522928478	4.869135802469136	-2.6461154603833723	ANTXR1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2234208586560773	4.5823152995927865	-2.441961042053517	FLT1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.23308143868508283	4.326732673267327	-2.2588473265567357	PIK3CA
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.24645557435666754	4.019969278033794	-2.037730229066884	PIK3CA
KEGG_2021_Human	Thermogenesis	1/232	0.25290994493508406	0.25654893694853853	3.7696007696007694	-1.8563524399324505	MTOR
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.25654893694853853	3.7696007696007694	-1.8563524399324505	PIK3CA
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.2931448934708504	3.184640522875817	-1.4307154955453085	PIK3CA
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	MTOR
